Insulin Resistance Is a Modifying Factor for Parkinson's Disease
Movement Disorders · 2025
DOI: 10.1002/mds.30039 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders, 2025. Verfasst von Alise Zagare und 11 weiteren Autor:innen. Beteiligte Einrichtung: Developmental and Cellular Biology, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg. Hauptthemen laut MEDLINE: Parkinson Disease, Insulin Resistance. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fonds National de la Recherche Luxembourg.
Abstract (Originalsprache)
Background
Parkinson's disease (PD) is the second most common, and the fastest‐growing neurodegenerative disorder with unclear etiology in most cases. Therefore, the identification of non‐genetic risk factors for PD pathology is crucial to develop effective preventative or therapeutic strategies. An increasing number of evidence suggests that central insulin resistance might have an essential role in PD pathology. Nevertheless, it is not clear whether insulin resistance arises from external factors/lifestyle, comorbidities such as type 2 diabetes or it can occur in a PD patient's brain independently from peripheral insulin resistance.
Objective
We aimed to investigate insulin resistance and its role in GBA1 mutation‐associated PD pathogenesis and phenotype severity.
Methods
Midbrain organoids, generated from induced pluripotent stem cells (iPSCs) of PD patients carrying the GBA1 ‐N370S heterozygous mutation (GBA‐PD) and healthy donors, were exposed to different insulin concentrations to modify insulin signaling function. Transcriptomics analysis was performed to explore insulin signaling gene expression patterns in GBA‐PD and to find a potential target for GBA‐PD‐associated phenotype rescue.
Results
The insulin signaling pathway genes show dysregulation in GBA‐PD. Particularly, we highlight that a knockdown of FOXO1 mitigates the loss of dopaminergic neurons and cellular death in GBA‐PD. Additionally, our findings suggest a promising therapeutic potential of the anti‐diabetic drug Pioglitazone in decreasing dopaminergic neuron loss associated with GBA‐PD.
Conclusion
Local insulin signaling dysfunction plays a substantial role in GBA‐PD pathogenesis, exacerbating dopaminergic neuron death. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Developmental and Cellular Biology, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
- Bioinformatics Core Unit, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
- Health Sciences Research Center, Faculty of Health Sciences Research, Faculty of Health Sciences, University of Beira Interior, Covilhã, Portugal.
- Bioimaging Platform, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
- Sequencing Platform, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
- Translational Neuroscience, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
ORCID-Profile: Paul Antony, Enrico Glaab, Jens C Schwamborn
Förderung
- Fonds National de la Recherche Luxembourg
Zitieren
APA
Zagare, A., Hemedan, A., Almeida, C., Frangenberg, D., Gomez-Giro, G., Antony, P., Halder, R., Krüger, R., Glaab, E., Ostaszewski, M., Arena, G., & Schwamborn, J. C. (2025). Insulin Resistance Is a Modifying Factor for Parkinson's Disease. Movement Disorders. https://doi.org/10.1002/mds.30039
Vancouver
Zagare A, Hemedan A, Almeida C, Frangenberg D, Gomez-Giro G, Antony P, et al. Insulin Resistance Is a Modifying Factor for Parkinson's Disease. Movement Disorders. 2025. doi:10.1002/mds.30039
BibTeX
@article{Zagare2025,
author = {Zagare, Alise and Hemedan, Ahmed and Almeida, Catarina and Frangenberg, Daniela and Gomez-Giro, Gemma and Antony, Paul and Halder, Rashi and Krüger, Rejko and Glaab, Enrico and Ostaszewski, Marek and Arena, Giuseppe and Schwamborn, Jens C},
title = {Insulin Resistance Is a Modifying Factor for Parkinson's Disease},
journal = {Movement Disorders},
year = {2025},
doi = {10.1002/mds.30039}
}
EUVIMED